Abu-Raddad LJ

A signature for biological heterogeneity in susceptibility to HIV infection?
Nagelkerke N, Abu-Raddad LJ, Awad SF, Black V, Williams BG

Infectious Disease Modelling

(2019)

https://doi.org/10.1016/j.idm.2018.08.002
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980 to 2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study
Frank TD, Carter A, Jahagirdar D, Biehl MH, Douwes-Schultz D, Larson SL, Arora M, Dwyer-Lindgren L, Steuben KM, Abbastabar H, Abu-Raddad LJ, Adetokunboh OO, et al

The Lancet HIV

(2019)

https://doi.org/10.1016/S2352-3018(19)30196-1
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation
Delva W, Abu-Raddad LJ, Gorgens M, Wilson D, Hallett TB, Welte A

PLoS Medicine

(2012)

https://doi.org/10.1371/journal.pmed.1001239